Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 126561 - 126580 out of 566103 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Canada | (L04AC18) risankizumab (adm: P) | Skyrizi (autoinjector) | Liq/Liq. SC 150 mg/mL,Autoinjector / auto-injecteur | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic | ABV |
| Canada | (L04AC18) risankizumab (adm: P) | Skyrizi (prefilled syringe) | Liq/Liq. SC 150 mg/mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic | ABV |
| Canada | (L04AC18) risankizumab (adm: P) | Skyrizi (cartridge) | Liq/Liq. SC 360 mg / 2.4 mL,Cartridge / cartouche | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic | ABV |
| Canada | (L04AC18) risankizumab (adm: P) | Skyrizi | Liq/Liq. SC 600 mg / 10 mL,Vial / fiole | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic | ABV |
| Canada | (L04AC19) satralizumab (adm: P) | Enspryng | Liq/Liq. SC 120 mg/mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
Neuromyelitis Optica | HLR |
| Canada | (L04AC21) bimekizumab (adm: P) | Bimzelx (autoinjector) | Liq/Liq. SC 160 mg/mL,Autoinjector / auto-injecteur | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | UCB |
| Canada | (L04AC21) bimekizumab (adm: P) | Bimzelx (prefilled syringe) | Liq/Liq. SC 160 mg/mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | UCB |
| Canada | (L04AC24) mirikizumab (adm: P) | Omvoh (autoinjector) | Liq/Liq. SC 100 mg/mL,Autoinjector / auto-injecteur | Ex-factory price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative | LIL |
| Canada | (L04AC24) mirikizumab (adm: P) | Omvoh (prefilled syringe) | Liq/Liq. SC 100 mg/mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative | LIL |
| Canada | (L04AC24) mirikizumab (adm: P) | Omvoh | Liq/Liq. SC 300 mg / 15 mL,Vial / fiole | Ex-factory price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative | LIL |
| Canada | (L04AD01) ciclosporin (adm: O) | Neoral | Liq/Liq. Orl 100 mg/mL,Millilitre / millilitre | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NVR |
| Canada | (L04AD01) ciclosporin (adm: O) | Neoral | Cap/Caps. Orl 10 mg,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NVR |
| Canada | (L04AE02) ozanimod (adm: O) | Zeposia (initiation pack) | Cap/Caps. Orl 0.23 mg, 0.46 mg,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting;Colitis, Ulcerative | BRI |
| Canada | (L04AE02) ozanimod (adm: O) | Zeposia | Cap/Caps. Orl 0.92 mg,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting;Colitis, Ulcerative | BRI |
| Canada | (L04AJ01) eculizumab (adm: P) | Soliris | Liq/Liq. IV 300 mg / 30 mL,Vial / fiole | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemoglobinuria, Paroxysmal | ALX |
| Canada | (L04AJ03) pegcetacoplan (adm: P, previous atc code l04aa54. new atc 4th level l04aj valid from january 2024.) | Empaveli | Liq/Liq. SC 1080 mg / 20 mL,Vial / fiole | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemoglobinuria, Paroxysmal | SBI |
| Canada | (M01AB15) ketorolac (adm: P) | Toradol | Liq/Liq. Inj 10 mg,Millilitre / millilitre | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | MTP |
| Canada | (M01AE02) naproxen | Pediapharm Naproxen | Sus/Susp. Orl 25 mg/mL,Millilitre / millilitre | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | MDX |
| Canada | (M03AX01) botulinum toxin | Dysport Therapeutic | Pws/Pd.S IM 300 Unit,Vial / fiole | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | IPS |
| Canada | (M03AX01) botulinum toxin | Dysport Therapeutic | Pws/Pd.S IM 500 Unit,Vial / fiole | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | IPS |
Pages
